What’s new in COVID TRIPS waiver negotiations?

Sangeeta Shashikant from the Third World Network looks at the position of different countries, how pharmaceuticals are profiting from the crisis, and the urgent need for the negotiations to be fast tracked and concluded.

June 01, 2021 by Peoples Dispatch

Sangeeta Shashikant from the Third World Network talks to us about new developments in the negotiations for the TRIPS-waiver on COVID related products at the World Trade Organization. She discusses the position of different countries, how pharmaceuticals are profiting from the crisis, and the urgent need for the negotiations to be fast tracked and concluded.

This interview is part of the People’s Health Dispatch, a fortnightly newsletter bringing news and analyses on health workers’ struggles, radical people-led initiatives, and the politics of global health. Here’s the link to subscribe to the newsletter: bit.ly/3uAcTTV

× To Subscribe